Cystic

- PK Data and Safety Profile Consistent with Previous Studies in Healthy Subjects – - Results Support Potential Utility of Lefamulin in Patients with Cystic Fibrosis - DUBLIN,…

Researchers at Oregon State University and Oregon Health & Science University have taken a key step toward improving and lengthening the lives of cystic fibrosis patients, who experience…

EMERYVILLE, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage biotherapeutics company harnessing the power of directed evolution…

Researchers call for better newborn screens across the U.S. Cystic fibrosis is missed more often in newborn screenings for non-white than white babies, creating higher risk for irreversible…

Health-related quality-of-life outcomes continued to be favorable with maintenance…

NASHVILLE, Tenn. -- Roughly one in 10 adults with cystic fibrosis also had a diagnosis of heart failure, according to a…

Enrollment has begun in an early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis (CF) who carry Pseudomonas aeruginosa (P. aeruginosa) in their lungs.…

Cara Murez MONDAY, Oct. 3, 2022 (HealthDay News) -- More than 160,000 people around the world have cystic fibrosis, and supplementing with vitamins C…

Combination of subcutaneous ELX-02 with ivacaftor did not achieve statistical significance for efficacy endpoints in Phase 2 study in Class 1 CF ELX-02 was well tolerated with no…

DUBLIN, Ireland and FORT WASHINGTON, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and…